(Q39492350)

12 September 2017

Investigation of cancer cell lines for peptide receptor-targeted drug development (English)

1 reference

12 September 2017

7

David H Coy

1 reference

12 September 2017

Lichun Sun

1

1 reference

12 September 2017

Jing Luo

2

1 reference

12 September 2017

L Vienna Mackey

3

1 reference

12 September 2017

Lynsie M Morris

4

1 reference

12 September 2017

Laura G Franko-Tobin

5

1 reference

12 September 2017

Keith T LePage

6

1 reference

12 September 2017

1 September 2011

1 reference

Journal of Drug Targeting

12 September 2017

1 reference

12 September 2017

19

1 reference

12 September 2017

8

1 reference

12 September 2017

719-730

1 reference

The effect of drug dose and drug exposure time on the binding, internalization, and cytotoxicity of radiolabeled somatostatin analogs

12 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.558089

Antibody-drug conjugates for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.558089

Somatostatin receptor subtype gene expression in human and rodent tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.558089

Targeted therapy of breast and gynecological cancers with cytotoxic analogues of peptide hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.558089

Tumor-penetrating peptides: a shift from magic bullets to magic guns.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.558089

An adjustable release rate linking strategy for cytotoxin-peptide conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.558089

Novel quinazoline-based compounds impair prostate tumorigenesis by targeting tumor vascularity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.558089

Targeted cytotoxic somatostatin analog AN-162 inhibits growth of human colon carcinomas and increases sensitivity of doxorubicin resistant murine leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.558089

Detection of somatostatin receptors in human osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.558089

What's wrong with our cancer models?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.558089

Utility of radiolabeled somatostatin receptor analogues for staging/restaging and treatment of somatostatin receptor-positive pediatric tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.558089

Distribution of mRNA for VIP and PACAP receptors in human cerebral arteries and cranial ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.558089

Subtype selective interactions of somatostatin and somatostatin analogs with sst1, sst2, and sst5 in BON-1 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.558089

21 January 2018

Tumor receptor imaging

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.558089

Receptor-mediated tumor targeting based on peptide hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.558089

In vitro and in vivo antitumor effects of cytotoxic camptothecin-bombesin conjugates are mediated by specific interaction with cellular bombesin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.558089

Somatostatin and its receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.558089

Peptide receptors as molecular targets for cancer diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.558089

Peptide-based probes for cancer imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.558089

Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.558089

New approaches to treatment of various cancers based on cytotoxic analogs of LHRH, somatostatin and bombesin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.558089

Application of high-throughput, molecular-targeted screening to anticancer drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.558089

The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.558089

Targeted chemotherapy with cytotoxic bombesin analogue AN-215 inhibits growth of experimental human prostate cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.558089

Effects of camptothecin conjugated to a somatostatin analog vector on growth of tumor cell lines in culture and related tumors in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.558089

Examination of the 1,4-disubstituted azetidinone ring system as a template for combretastatin A-4 conformationally restricted analogue design

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.558089

Effects of camptothecin on tumor cell proliferation and angiogenesis when coupled to a bombesin analog used as a targeted delivery vector

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.558089

Inhibition of growth of experimental human and hamster pancreatic cancers in vivo by a targeted cytotoxic bombesin analog.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.558089

Antibody-drug conjugate targets

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.558089

Spotlight on molecular profiling: "Integromic" analysis of the NCI-60 cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.558089

The human gastrin-releasing peptide receptor gene structure, its tissue expression and promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.558089

Radiometal targeted tumor diagnosis and therapy with peptide hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.558089

10.3109/1061186X.2011.558089

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference